Search clinical trials for: Pathological Cancer Progression

Total 10000 results

National Taiwan University Hospital

Active, not recruiting

The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.

Liver Cancer | Pembrolizumab | Lenvatinib | Atezolizumab

Taiwan
SystImmune Inc.

Recruiting

BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy

Bladder Cancer | Urothelial Carcinoma Bladder | Urothelial Cancer | Bladder Cancer Recurrent | Urothelial Carcinoma Recurrent | Metastatic Urothelial Cancer | Bladder Cancer Stage IV | Urothelial Carcinoma of the Urinary Bladder | Bladder Ca | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial... and other conditions

United States
University of British Columbia

Not yet recruiting

Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression (MIRA)

Uterine Neoplasms | Endometrial Hyperplasia | Endometrial Cancer | Menstrual Cycle | Uterine Cancer | Uterine Bleeding | Endometrial Intraepithelial Neoplasia | Reproductive Endocrinology

Canada
Assiut University

Not yet recruiting

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Bladder Carcinoma | Urothelial Bladder Carcinoma | Non-Muscle-Invasive Bladder Cancer (NMIBC) | Muscle-Invasive Bladder Cancer (MIBC)
Women's Cancer Study Group GmbH
AstraZeneca

Recruiting

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment (CAPIcorn)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast Cancer

Germany, Belgium, Portugal

Search clinical trials for: Pathological Cancer Progression

This is a preview